One of the more controversial figures at the FDA over the past decade quietly retired late last month. Tom Laughren, who was the director of the Division of Psychiatry Products in the Office of New Drugs in the Center for Drug Evaluation and Research, departed the FDA after spending nearly 20 years at the agency, an FDA spokeswoman confirms.
A board certified psychiatrist who co-authored numerous medical papers, he oversaw FDA approval, labeling decisions and guidance documents that influenced the fate some of the best-known psychiatric drugs marketed in the US and helped make him one of the more notable figures in the field of psychiatry.
Laughren, who began his FDA career as a clinical reviewer in the former Division of Neuropharmacological Drug Products in 1986, also played a pivotal role several years ago in the agency handling of a pair of long-running controversies over the safety and use of antidepressants and antipyschotics in young children.
At the time, many antipsychotics were not approved for children, although prescribing was widespread, despite the risks of such side effects as weight gain and diabetes. Meanwhile, there was growing public pressure to increase warnings about the risk of suicide in youngsters who were treated with antidepressants.
For these reasons, Laughren was often on the hot seat at FDA advisory committee meetings and at Congressional hearings (this is an example), where he was a lightning rod for critics who complained the agency was failing to protect public health by not moving faster to warn physicians and patients of the inherent risks of the medicines.
After some emotional FDA advisory meetings in 2004 and 2005, for instance, the agency added Black Box warnings to antidepressants. Laughren, however, later caused a stir when he publicly considered repealing the warnings after studies suggested suicide rates among youngsters were rising because too many doctors feared prescribing the pills (back story).
In 2008, an FDA advisory committee chastised the agency for not doing more to discourage antipsychotic prescribing to youngsters for unapproved uses. The scolding took place during what was to have been a routine meeting of pediatric safety of two antipsychotics, but the panel members expressed disappointment with FDA efforts.
Laughren was on hand to defend the FDA, and his own division. He responded by saying there was little the FDA could do and, instead, largely blamed medical societies, which he maintained were in a better position to alert and educate physicians about side effects and the potential risks involved (back story).
"What was he doing during this period when misrepresentations and misconduct was occurring? Labels were being updated to reflect safety concerns that should have been addressed sooner," says Stephen Sheller, an attorney who has filed lawsuits against Johnson & Johnson (JNJ) that claim its Risperdal antipsychotic caused gynecomastia – the abnormal development of large mammary glands in males – and that labels lacked sufficient warnings.
At the same time, Laughren was respected in the pharmaceutical industry for some of his decisions. In 2007, for instance, he disagreed with a three-person team of FDA medical reviewers, who urged that the Zyprexa antipsychotic sold by Eli Lilly (LLY) should be rejected for pediatric use because of inconsistent data from studies in US and Russian teens (back story).
Such moves, however, prompted some FDA critics, such as Alliance for Human Research Protection, to complain that his appearances on consensus treatment panels that sometimes included industry representation and backing smacked of a conflict of interest. The FDA rejected the accusation.
An FDA spokeswoman writes us that one of the last projects in which Laughren was involved was working on a guidance document for prospectively assessing for suicidal ideation and behavior in drug trials. She adds that his retirement had been planned. Laughren could not be reached for comment.






186 Comments
Observer is right. Laughren will have a lot of pharma offers, but he can't accept any of them for at least one year, I believe because of FDA's non-compete rules. They may have eliminated that rule so that guys like TL can bet a bite of the golden goose that much earlier.
Well I remember testifying - in the public part of the FDA hearings - and this man appeared/pretended to be asleep, always looking down.
Tracing his "track record", as Pharmalot has done to some degree here, shows a sorry story of refuting, time and again, his own advisory committees in his quest to be the perfect Pharma Boy.
Here's hoping this is the beginning of a thorough housecleaning in CDER.
The statistics of innocent people killed due to the side effects of psychiatric drugs is a long one. Though it is almost impossible to get the figures from the FDA itself, SSRI Stories tells of some of the carnage from this class of drugs. As for deaths from the atypical antipsychotics, the toll - of young people with mental health conditions (real or imagined)and old people given these drugs in nursing homes as sedatives - is high with numbers hard to come by.
Would that the Congress, whose members are elected to look after their constituents, would do so instead of protecting pharma and those at the FDA who do its bidding. And that the Administration, which oversees HHS and the FDA, would revamp the entire system and prosecute those responsible for what are clearly crimes within the industry.
The FDA, first of all, moved the hearing with no warning. The public comment period was gut and heart-wrenching, with many family members testifying that their loved one had committed suicide because of the drug, and urging stronger warnings on the labels.
It is beyond me how this man, Dr. Laughren, could have sat through all these stories over the years and yet continue to do what he did - defeat every attempt as long as possible to place any warnings on the SSRI/SNRI and atypical antipsychotic drugs, thus assuring that thousands of innocent people would die from their lethal side effects.
Unlike Leber, who seemed to relish a good argument, he seemed to prefer avoiding confrontation. Once he was the "decider", he had industry in his face a lot, thanks to frequent PDUFA-mandated meetings. By contrast, the public and academia got to tell him what they thought a lot less frequently (esp. AC meetings). If you're a ref calling a game, and you know one of the teams is going to yell at you later, it's probably tempting to let the yelling team be the one you're shielded from.
from wikipedia:
"Generally speaking, genocide does not necessarily mean the immediate destruction of a nation, except when accomplished by mass killings of all members of a nation. It is intended rather to signify a coordinated plan of different actions aiming at the destruction of essential foundations of the life of national groups, with the aim of annihilating the groups themselves. The objectives of such a plan would be the disintegration of the political and social institutions, of culture, language, national feelings, religion, and the economic existence of national groups, and the destruction of the personal security, liberty, health, dignity, and even the lives of the individuals belonging to such groups."
Epidemiologically, the warnings against prescribing antidepressants in young people had no detectable impact on suicide rates. http://www.ncbi.nlm.nih.gov/pubmed/19367564
According to CDC statistics, the 2003 warnings led to no change in the suicide rate among children in the US. For children age 5-17,the suicide rate in 2001-3 NHANES study was 1.8 per 100,000. (0.0018%). After the discussions of antidepressant-related suicides in 2004 to 2005 and the addition of black box warnings against using SSRIs in children, the rate remained constant at this same value in the next available measurement period, 2007-9.
How about all those thousands of deaths among adults? According to CDC, the rate of suicide among adults peaked in the year prior to the advent of SSRIs (1986) at 13 cases per 100,000. It fell steadily to 10.4 in the year 2000, and has slowly climbed back to 11.8 post 9/11. Its still 10% lower than it was the year before Prozac was approved.
A veteran's administration study of 225,866 veterans found that among veterans with diagnosis of depression, antidepressants exerted a protective effect against suicide. http://www.ncbi.nlm.nih.gov/pubmed/17606656
A Canadian study found that adults with a diagnosis of schizophrenia who regularly filled their prescriptions were are significantly reduced risk of suicide and all cause mortality. http://www.ncbi.nlm.nih.gov/pubmed/17213012
A Danish study found similar effects for antidepressants in recently discharged depression patients. http://www.ncbi.nlm.nih.gov/pubmed/17453694
I can go on, but take a look in Pubmed. The weight of scientific evidence that antidepressants and antipsychotics have a protective or at worst neutral role on suicide and overall mortality in adults is quite strong.
Or maybe its just a vast conspiracy.....
I guess you didn't attend either hearing to listen to the parents of children, or spouses, describe what happened when family members - perhaps after being given an SSRI for something nebulous like a stomach ache (remember, these drugs were and are heavily marketed to primary care docs) committed suicide from akithisia-induced side effects from them. I guess you haven't lived the long, lingering years having outlived your child who died of one of so many possible side effects from an atypical antipsychotic.
Laughren may have avoided confrontation, but he sat there year after year listening to families beg for stronger warnings, and refuting the advice of advisory committeess, going in favor of industry, always. All I can do is be thankful he's gone.
The reason that I ask is that 20 years of employment in the federal govt was and may still be a pension milestone. Budget negotiations may cause federal employee pension and other benefit reductions, so it would make sense for someone like Laughren to leave before any cuts are made.
Thanks for the note. Laughren joined the FDA in 1983. Before that, he was affiliated with the VA Medical Center in Providence, Rhode Island, and was on the faculty of the Brown University Program in Medicine.
Hope that helps, ed
And you would be caviling about how unprofessional and not serious the people presenting their stories to the FDA were if they weren't all "prepped and groomed". In order to families to collect enough data to match the data the FDA and sponsor HAVE, they'd have to hire a CRO to do data management for them.
The "circus" was FDA's creation - they set the rules for the format - how they will accept information from the public. You're complaining that there was a net under the tightrope walker....
Asclepios can caterwaul all he/she wants. Read David Healy's excellent "Pharmageddon", or Martha Rosenberg's "Born With A Junk Food Deficiency"or, for that matter, Robert Whitaker's "Anatomy of An Epidemic" to get a real sense of the damage these drugs have done.
The claim of large numbers of excess suicides is further excluded by the absence of an increased suicide rate in the total population after they were introduced.
Schizophrenia and depression were known to be associated with elevated risk of self harm long before SSRIs and atypical antipsychotics became available.
Yes, sometimes people do commit suicide after taking a drug. Lots do without taking drugs too. Anecdotes, no matter how tragic, are not a firm basis for making policy.
And if your doctor prescribed an SSRI for a stomach ache, I'd call your state medical board to discuss having his license pulled.
When, for example we have seen the same people get up there time after time after time representing the National Association for the Advancement of Fat Acceptance (yes, that's a real group) testify at a weight loss drug hearing, the room tends to empty faster than a New York Jets crowd losing a game to the Patriots 35-0 at halftime. Need some new folks up there.
However, the process (public comment period) has been made stressful and demeaning by the FDA...it's like a cattle call. Take a number and start to speak when the light goes on...if you are in mid-sentence and the three minute time is up, the microphone is shut off. One would think the FDA would welcome actual input from family members, even if anecdotal, but clearly the only reason the comment period happens is that it is in the regulations or law. At least this is the way things were handled in Dr. Laughren's psychiatric drug advisory committee meetings.
As for SSRI/SNRIs and atypicals causing suicidal impulses/akithisia, I am not a researcher but I know many families who have lost children and spouses to this very thing. One family I knew, the son had manic depression and had done fine on lithium, never feeling suicidal, but an atypical was added and he had to go into the hospital several times to be safe from self-harm.
Having said that, I think its important to avoid the temptation to throw out the conclusions of large controlled studies based on tragic anecdotes. Most people who die of heart failure are taking beta blockers. Many of the die shortly after starting beta blocker therapy. But we know from both randomized clinical trials and large case control studies that beta blockers extend rather than reducing life expectancy in HF.
There are alternatives. Read the book and think about it. It is a hopeful read in this regard.
No way to collect data, which is what we are talking about here.
The rules of how data is collected at a site participating in a clinical trial can absolutely be applied in this situation as well. All these families have medical records, no? Develop a case report form to collect the information that is KNOWN not to have been collected through the process currently in place for spontaneous reporting of adverse events after a drug is on the market.
Robert Whitaker, "Mad in America- Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill", Perseus Publishing, 2002.
My neighbor, Will Stevens, is a plumber who wrote an excellent book on theromodynamics last year. He's having a little trouble getting it published, but he has proved conclusively that is possible to prevent global warming with a worldwide array of power stations that generate electricity from water as the only input.
Obviously the mainstream engineers have had it criminally wrong for over 100 years now, but hopefully once Mr. Steven's book comes out the worldwide conspiracy of the utility companies will be brought to a halt.
http://rt.com/news/ferret-circus-ape-parrot/
http://www.riverdeep.net/current/2002/03/032502t_cowpower.jhtml
When you step back and take a look at the time period in which this was state of the art therapy, the only explanation for this is cultism and elitism in the profession. This treatment evolved OUTSIDE of the science-based culture present in the USA during the same time frame. Meaning, no one was recruited to be on the team who would have given the *blink blink* incredulous emoticon to the dominating medical authority who was selling this cockamani idea.
Considering that the industry is finally admitting to a less than stellar pipeline and is solving the immediate economic problem for *shareholders* by dismantling science-driven teams in favor of small elite cults chasing the sci fi fantasies of *inwestors* with snappy computer software presentations, progress is definitely not around the corner.
At least in astrophysics, they are not making the claim that *gravity* might not be as important of a factor as they previously thought and tweaking gravity here and there is a good idea to bend the curve in favor of profit - or wha'ever theory one woke up with today hoping to win the a---hole of the day award....
Gravity is to physics as DNA is to biology. Hey, it's a *theory*.
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1949/moniz-bio.html
And who inspired Egas Moniz?
http://www.google.com/search?q=headshrinkers&hl=en&tbo=u&rlz=1C1AVSA_enUS424US424&tbm=isch&source=univ&sa=X&ei=ZjzGUJrlLJOy0AGbxYHIAg&ved=0CEgQsAQ&biw=1366&bih=635
http://www.head-hunter.com/prep.html
Meanwhile, we have a visual for *benzene abuse" for those out there who are either self-medicating or trying to keep up with working 3 jobs:
http://www.huffingtonpost.com/2012/12/06/horrors-of-methamphetamin-rehabscom-photos_n_2240401.html
Socioeconomics - FDA doesn't get involved with meth lab quality control, and neither does the IRS with taxing the job creators...
Way off topic, but the single rock thrown in the pond sends out circle after circle of ripples...and, ultimately, there are dead bodies to bury. Hurt *feelings* all around...?
http://beta.photobucket.com/images/Meth+Mouth/#/images/Meth+Mouth/?&_suid=135517148997604590511364679476
http://www.hindawi.com/journals/ijd/2010/786503/
This is the cultism and elitism to which I was referring to - what, exactly, was the problem that the housewife, Alice Hood Hammatt, from Topeka, KS have that made her his first subject?
Much too complicated of a conspiracy for me, I'll have to leave it to others to sort out.
Pages